Kansas HIE will dissolve

Kansas - 54.06 Kb
The board of directors of the Kansas health information exchange (KHIE) has voted to dissolve itself and turn its operation over to the Kansas Department of Health and Environment (KDHE), according to a report from the Kansas Health Institute (KHI).

Finances are an issue for the public-private partnership. With its grant from the Office of the National Coordinator for Health IT set to run out in 2013, the organization needed about $400,000 to cover annual operating costs.

A state-run HIE would cost about $54,000; KDHE anticipates in its transition plan combining the two entities that the move to KDHE will create first-year savings of $232,900 and second-year savings of $390,600.

In the report, KDHE also said that the transition is a logical progression since KHIE had evolved into a "policy-defining entity," and that most of the needed policies had been completed or were nearing completion.    

The Kansas Legislature will need to approve the transition, which is expected, according to KHI. 

The dissolution does not reflect on data-sharing capabilities. In fact, Wesley Medical Center and Via Christi Health, Kansas' two largest health systems, recently demonstrated their interoperability by sharing data via Wichita HIE, an affiliate of the Kansas Health Information Network, a private HIE created by the Kansas Medical Society and the Kansas Hospital Association. 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.